Screening of brain metastasis with limited Magnetic Resonance Imaging (MRI): Clinical implications of using limited brain MRI during initial staging for non-small cell lung cancer patients

Journal of Korean Medical Science

Volumn 20, Issue 1, 2005, Pages 121-126

  Kim, Sun Young ^a   Kim, Jae Sung ^a   Park, Hee Sun ^a   Cho, Moon June ^a   Kim, Ju Ock ^a   Kim, Jin Whan ^a   Song, Chang Jun ^a   Lim, Seung Pyung ^a   Jung, Sung Soo ^a,b  

^a Chungnam National University   (South Korea)

^b Chungnam National University College of Medicine   (South Korea)

Author keywords

Carcinoma; Diagnosis; Magnetic Resonance Imaging; Neoplasm Metastasis; Neoplasm Staging; Non Small Cell Lung; Radiography

Indexed keywords

ADULT; AGED; ARTICLE; BRAIN METASTASIS; BRAIN RADIOGRAPHY; CANCER SCREENING; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; FEMALE; HUMAN; INCIDENCE; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; NEUROLOGIC DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; PROSPECTIVE STUDY; QUALITY OF LIFE; STATISTICAL SIGNIFICANCE; SURVIVAL TIME;

EID: 14844320494     PISSN: 10118934     EISSN: None     Source Type: Journal    
DOI: 10.3346/jkms.2005.20.1.121     Document Type: Article

References (26)

1. Minna J. Neoplams of the lung. In: Braunbald E, Fauci AS, Kasper DL, Hauser SL, Longo DL, Jameson JL, editors. Harrison's principles of internal medicine. 15th ed. New York: McGraw-Hill, Inc. 2001: 562-71.
2. Sorensen JB, Hansen HH, Hansen M, Dombemowsky P. Brain metastases in adenocarcinoma of the lung: frequency, risk groups, and prognosis. J Clin Oncol 1988; 6: 1474-80.
3. Zabel A, Milker-Zabel S, Thilmann C, Zuna I, Rhein B, Wannenmacher M, Debus J. Treatment of brain metastases in patients with non-small cell lung cancer (NSCLC) by stereotactic linac-based radiosurgery: prognostic factors. Lung Cancer 2002; 37: 87-94.
4. Vines EF, Le Pechoux C, Arriagada R. Prophylactic cranial irradiation in small cell lung cancer. Semin Oncol 2003; 30: 38-46.
5. Yokoi K, Kamiya N, Matsuguma, H, Machida S, Hirose T, Mori K, Tominaga K. Detection of brain metastasis in potentially operable non-small cell lung cancer. A comparison of CT and MRI. Chest 1999; 115: 714-9.
6. Hochstenbaga MM, Twijnstra A, Hofman P, Wouters EF, ten Velde GP. MR-imaging of the brain of neurologic asymptomatic patients with large cell or adenocarcinoma of the lung. Does it influence prognosis and treatment? Lung Cancer 2003; 42: 189-93.
7. Virgo KS, McKirgan LW, Caputo MC, Mahurin DM, Chao LC, Caputo NA, Naunheim KS, Rye MW, Gillespie KN, Johnson FE. Post-treatment management options for patients with lung cancer. Ann Surg 1995; 222: 700-10.
8. Yokoi K, Miyazawa N, Arai T. Brain metastasis in resected lung cancer: value of intensive follow-up with computed tomography. Ann Thorac Surg 1996; 61: 546-51.
9. Cole FH Jr, Thomas JE, Wilcox AB, Halford HH 3rd. Cerebral imaging in the asymptomatic preoperative bronchogenic carcinoma patient: is it worthwhile? Ann Thorac Surg 1994; 57: 838-40.
10. Silvestri GA, Littenberg B, Colice GL. The clinical evaluation for detecting metastatic lung cancer. A meta-analysis. Am J Respir Crit Care Med 1995; 152: 225-30.
11. Andre F, Grunenwald D, Pujol JL, Girard P, Dujon A, Brouchet L, Brichon PY, Westeel V, Le Chevalier T. Patterns of relapse of N2 non-small cell lung cancer patients treated with preoperative chemotherapy. Should prophylactic cranial irradiation be reconsidered? Cancer 2001; 91: 2394-400.
12. Gasper L, Scott C, Rotman M, Asbell S, Phillips T, Wasserman T, McKenna WG, Byhardt R. Recursive partitioning analysis (RPA) of prognostic factors in three radiation therapy oncology group (RTOG) brain metastatses trials. Int J Radiaton Oncol Biol Phys 1997; 37: 745-51.
13. Ceresoli GL, Reni M, Chiesa G, Carretta A, Schipani S, Passoni P, Bolognesi A, Zannini P, Villa E. Brain metastases in locally advanced nonsmall cell lung carcinoma after multimodality treatment; risk factors analysis. Cancer 2002; 95: 605-12.
14. Walsh GL, O'Connor M, Willis KM, Milas M, Wong RS, Nesbitt JC, Putnam JB Jr, Lee JJ, Roth JA. Is follow-up of lung cancer patients after resection medically indicated and cost-effective? Ann Thorac Surg 1995; 60: 1563-72.
15. Sze G, Milano E, Johnson C, Heier L. Detecton of brain metastases: comparison of contrast-enhanced MR with unenhanced MR and enhanced CT. Am J Neuroradiol 1990; 11: 785-91.
16. Davis PC, Hudgins PA, Peterman SB, Hoffman JC Jr. Diagnosis of cerebral metastases: Double-dose delayed CT vs contrast-enhanced MR imaging. Am J Neuroradiol 1991; 12: 293-300.
17. Haberkorn U, Schoenberg SO. Imaging of lung cancer with CT, MRI and PET. Lung Cancer 2001; 34 (Suppl 3): 13-23.
18. Kwon SJ, Lee YS, Ahn JY, Jung SS, Kim JO, Kim SY. Detection of brain metastases using limited brain magnetic resonance imaging. Tuberculosis and Respiratory Diseases 2003; 55: 499-505.
19. Choi NC, Carey RW, Daly W, Mathisen D, Wain J, Wright C, Lynch T, Grossbard M, Grillo H. Potential impact on survival of improved tumor downstaging and resection rate by preoperative twice-daily radiation and concurrent chemotherapy in stage IIIA non-small cell lung cancer. J Clin Oncol 1997; 15: 712-22.
20. Eberhardt W, Wilke H, Stamatis G, Stuschke M, Harstrick A, Menker H, Krause B, Mueller MR, Stahl M, Flasshove M, Budach V, Greschuchna D, Konietzko N, Sack H, Seeber S. Preoperative chemotherapy followed by concurrent chemoradiation therapy based on hyperfractionated accelerated radiotherapy and definitive surgery in locally advanced non-small cell lung cancer: Mature results of phase II trial. J Clin Oncol 1998; 16: 622-34.
21. Stuschke M, Eberhardt W, Pottgen C, Stamatis G, Wilke H, Stuben G, Stoblen F, Wilhelm HH, Menker H, Teschler H, Muller RD, Budach V, Seeber S, Sack H. Prophylactic cranial irradiation in locally advanced non-small cell lung cancer after multimodality treatment: long-term follow-up and investigations of late neuropsychologic effects. J Clin Oncol 1999; 17: 2700-9.
22. Mintz BJ, Tuhrim S, Alexander S, Alexander S, Yang WC, Shanzer S. Intracranial metastases in the initial staging of bronchogenic carcinoma. Chest 1984; 86: 850-3.
23. Hooper RG, Tenholder MF, Underwood GH, Beechler CR, Spratling L. Computed tomographic scanning of the brain in initial staging of bronchogenic carcinoma. Chest 1984; 85: 774-6.
24. Gregor A. Prevention and management of brain metastases. Lung Cancer 2003; 41 (Suppl 3): 42.
25. Robnett TJ, Machtay M, Stevenson JP, Algazy KM, Hanh SM. Factors affecting the risk of brain metastases after definitive chemoradiation for locally advanced non-small cell lung cancer. J Clin Oncol 2001; 19: 1344-9.
26. Fujita A, Fukuoka S, Takabatake H, Tagaki S, Sekine K. Combination chemotherapy of cisplatin, ifosfamide, and irinotecan with rhG-CSF support in patients with brain metastases from non-small cell lung cancer. Oncology 2000; 59: 291-5.